Integrating genomic features for non-invasive early lung cancer detectionJacob J. Chabon, Maximilian Diehn, Chih Long Liu et al.|Nature|2020Cited by 689
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancerEverett J. Moding, Maximilian Diehn, Yufei Liu et al.|Nature Cancer|2020Cited by 369
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint InhibitionBarzin Y. Nabet, Maximilian Diehn, Mohammad Shahrokh Esfahani et al.|Cell|2020Cited by 360
<i>KEAP1/NFE2L2</i> Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase InhibitionMichael S. Binkley, Maximilian Diehn, Young-Jun Jeon et al.|Cancer Discovery|2020Cited by 172
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLCMatthew D. Hellmann, Maximilian Diehn, Barzin Y. Nabet et al.|Clinical Cancer Research|2020Cited by 123